Rightangled is a DNA testing company backed by NHS that delivers services to consumers and medical/fitness specialists. The company is a full CQC healthcare provider license that has achieved registration with Bupa, a leading medical insurance company. The company is now planning to move into AI with a solid database. Rightangled has received excellent customer reviews with 5* on Google and 4.5* on Trustpilot. With the proceeds, the company will seek to launch its application, create a strong AI central system, and grow into new markets (US& UAE).
days to go:
Expired
investment:
£311,690
Almond provides businesses and consumers with a method to understand their carbon footprint and use the company's proprietary offset tools to become carbon neutral. Consumers can earn Almond Tokens when purchasing products from Almond's partnering sustainable brands. The Almond Tokens can be spent on their website The Almond certification label on products enables them to demonstrate their commitment to protecting the environment, consumer health and building a better society for all. The core idea is to build a market that's geared towards sourcing and selling sustainable products. The green economy market is worth $4 trillion. The offset market was $300 million in 2018, having grown over 140-fold in 10 years. Almond seeks to be a market leader in this domain. It has also partnered with reputed institutions such as the World Wildlife Fund, and the Stockholm Environment Institute (carbon analytics). With the investment, the company aims to further the popularity of its existing Almond App and have more people join its ecosystem.
days to go:
Expired
investment:
£522,540
Launched in 2015, Gone West plans to disrupt the commercial forestry sector by adopting regenrative forestry systems in place of traditional ones, thereby creating environmental and social benefits. The company has planted millions of trees and has become pretty good at it. The company's product development team is engineering solutions for environmental problems, such as its Green Light app. The company's business model is structured to provide diverse yet interconnected revenue streams. Gone West has been self-funded to this date with increasing year-on-year revenue growth since launch. With the proceeds, the company will invest 30% for operations, 20% for Marketing, 5% for Business Innovation, 20% for Forestry Services, 15% for Product development, 10% for Plant and Protect.
days to go:
Expired
investment:
£159,300
Accunea is the world’s first real-time continuous organ function monitoring company, specializing in biomarkers for kidney transplantation. Targeting NHS hospitals in the UK undertaking renal transplantation, the company aims to provide relief to patients awaiting organ transplants by ensuring availability of more organs for transplant and reducing the numbers of deaths due to increasing waiting list times. For this purpose, the company has designed a miniature analysis device which constantly monitors markers of kidney function and metabolism through a standard dribble line put into the vein of a patient. Accunea is raising £400,000 at a pre-money valuation of £2,230,000. The funds will be used to achieve clinical utility in Kidney and Pancreas.
days to go:
Expired
investment:
£388,038
Elemental is an agricultural food technology company that converts 78% of beef processing waste into sustainable fertiliser. The company claims that its technology can potentially reduce global beef CO2 emissions equivalent to 50 million cattle. Elemental asserts that its technology has been developed through extensive R&D and protected by patents in 60+ countries. The company raised £1.5 million on Crowdcube in late 2019, signed agreements for 14 projects in the UK and Europe using its technology, built a demonstrator plant and agreed to install its technology on commercial terms at 6 UK abattoirs. The company states they will use the investment to operationalise their first plant by December 2021 and grow their business across different verticals.
days to go:
Expired
investment:
£1,395,801
ClearWaste is a price comparison website for waste removal and a provider of enforcement services to councils across the UK. The company argues that the cost to local authorities and taxpayers for cleaning up fly-tipping in England in 2016/17 was £57.7 million and is now thought to exceed £100 million. ClearWaste is on a mission to combat it through its app and web platform utilising reporting and prevention methodologies. The company links consumers with govt-registered waste removers backed by a £1k no-fly-tipping guarantee. ClearWaste argues that the UK waste industry is worth over £6.8 billion and supports more than 103,000 jobs. It aims to be a contender in this segment. ClearWaste has featured in press entities such as BBC, ITV, Channel 5, Sky, Times, and The Guardian. It was also a finalist at the National Recycling Awards 2020. ClearWaste will use the investment to develop its sales and marketing functions and further raise brand awareness.
days to go:
Expired
investment:
£199,599
Plantwork Systems (PWS) is an eco-conscious, technology company providing sustainable and environmentally friendly solutions to the wastewater treatment industry. It is the developer, owner, and provider of a range of proprietary technologies such as TN-REM, NUTREM®, and the deHoxar Spiral Separator. These products aid in nutrient removal, improved filtration, sludge thickening. This leads to wastewater treatment plants recycling more water, reducing their energy requirements, and minimising water scarcity. The company has generated combined revenues of £1.44 million since July 2017. PWS is seeking funding of up to £1 million, at a pre-money valuation of £6 million. It will use the investment to accelerate its growth and bring more innovative products to the market.
days to go:
Expired
investment:
£244,865
My Tree has launched a Memorial Park in the UK that enables people to plant a tree with the ashes of their loved one. It is the sole exclusive UK memorial park which offers ashes burial with the planting of a tree. The company is in discussion with DoubleTree Hilton and First Funerals. My Tree has launched its first park five miles outside of Reading and 38 miles from London. The company will use the funds to promote the site, do pre-planting to maximize usage of space and support plans to open more sites by the end of 2020.
days to go:
Expired
investment:
£160,380
EnXray are developing Low Energy X-ray (LEXR) technologies to sterilise equipment in commercial or research settings where low volume/high value therapeutic products, such as cancer vaccines and stem cell implants are being developed. Their aim is to reduce the need for third party providers and have the sterilisation process done on-site and on-demand with simple and safe equipment to reduce cost and save time for medical research organisations.
days to go:
Expired
investment:
£376,230
TC BioPharm is an immunotherapy company. It has used its patented technology to harness the power of a particular part of the immune system, Gamma Delta T-cells (GDT), to negate cancer cells in the human body. TC BioPharm has treated terminally ill patients with acute myeloid leukaemia in approved clinical trials garnering positive responses from multiple patients. The company has received regulatory approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to run a COVID-19 clinical trial to address the global pandemic. TC BioPharm aims to use its current technology to provide a frozen product that can be manufactured cost-effectively and distributed globally. The company has already raised over £7 million in the last 15 months. It will use the investment to take its clinical trials forward in COVID-19 and cancer.
days to go:
Expired
investment:
£1,753,067
